Director/PDMR Shareholding | RNS | Ticker

/News/RNS

Director/PDMR Shareholding

RNS Announcement

RNS Number : 6103Q

GlaxoSmithKline PLC

30 November 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

Details of PDMR/person closely associated with them ('PCA')

Name

Mr S Dingemans

Position/status

Chief Financial Officer

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The grant of options over Ordinary Shares pursuant to the Company's ShareSave Plan 2016.

Price(s) and volume(s)

Price(s)	Volume(s)
£12.95	208

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-11-30

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr S A Hussain

Position/status

President, Global Pharmaceuticals

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The grant of options over Ordinary Shares pursuant to the Company's ShareSave Plan 2016.

Price(s) and volume(s)

Price(s)	Volume(s)
£12.95	694

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-11-30

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr P C Thomson

Position/status

SVP, Communications & Government Affairs

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

The grant of options over Ordinary Shares pursuant to the Company's ShareSave Plan 2016.

Price(s) and volume(s)

Price(s)	Volume(s)
£12.95	277

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-11-30

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQBLFXQFFEFBB

RNS metadata

Title: Director/PDMR Shareholding
Time: 16:52:29
Date: 30 Nov 2016
Category: Director/PDMR dealings
ID: 6103Q